RESUMEN
Introduction: Objective: to investigate the speed of weight gain (WG) and the z-score (E-z) of weight in premature neonates large for gestational age (LGA) during four weeks of hospitalization. Methods: a retrospective longitudinal study with premature neonates in a neonatal intensive care unit at a university hospital. Data were obtained from January 2017 to December 2018; 115 babies with gestational age (GA) ≥ 27 and < 37 weeks, non-twin, AGA or LGA were included. The WG (g/kg/day) was obtained from the nadir weight and the E-z was calculated online based on the Intergrowth-21st curves. Repeated-measures ANOVA and multiple linear regression were used to assess the association between WP and E-z and explanatory variables; p < 5 %. Results: mean GA was 32.5 weeks, birth weight was 1910 g and weight loss was 5 % at 7 days. WG was lower in LGA babies, with GI between 32 and 37 weeks (LGA, 9.2 ± 5.6 g/kg/day vs AGA, 13.9 ± 6.0 g/kg/day). The change in WG was explained by protein supply in AGA (B = 2.5 g/kg/day; 95 % CI, 0.7 to 4.3; and ß = 0.543) and by GA in LGA (B = -0.05 g/kg/day; 95 % CI, -0.09 to -0.02; and ß = -0.574). In the 4th week of hospitalization, weight E-z decreased similarly for LGAs and AGAs, and this variation was explained by growth. Conclusions: premature LGAs had lower WG compared to AGAs during the neonatal period. The linear and brain growth explained the variation in weight E-z among these preterms.
Introducción: Objetivo: Investigar la velocidad de la ganancia de peso (GP) y la puntuación z (E-z) de peso en neonatos prematuros grandes para la edad gestacional (GEG) durante cuatro semanas de hospitalización. Métodos: estudio longitudinal retrospectivo con neonatos prematuros de una unidad de cuidados intensivos neonatales de un hospital universitario. Los datos se obtuvieron desde enero de 2017 hasta diciembre de 2018. Se incluyeron 115 bebés con edad gestacional (EG) ≥ 27 y < 37 semanas, no gemelos, AEG o GEG. El GP (g/kg/día) se obtuvo a partir del peso nadir y el E-z se calculó en línea basado en las curvas Intergrowth-21st. Se utilizaron el ANOVA de medidas repetidas y la regresión lineal múltiple para evaluar la asociación entre GP y E-z y las variables explicativas; p < 5 %. Resultados: la EG media fue de 32,5 semanas, el peso al nacer de 1910 g y la pérdida de peso del 5 % a los 7 días. El GP fue menor en los bebés GEG, con EG entre 32 y 37 semanas (GEG: 9,2 ± 5,6 g/kg/día vs. AEG: 13,9 ± 6,0 g/kg/día). El cambio en el GP se explicó por el suministro de proteínas en los AEG (B = 2,5 g/kg/día; IC 95 %: 0,7 a 4,3; y ß = 0,543) y por EG en los GEG (B = -0,05 g/kg/día; IC 95 %: -0,09 a -0,02; y ß = -0,574). En la 4ª semana de hospitalización, el peso E-z se redujo de manera similar en los GEG y los AEG, y esta variación se explicó por el crecimiento. Conclusiones: los prematuros GEG tuvieron un menor GP en comparación con los AEG durante el periodo neonatal. El crecimiento lineal y cerebral explicó la variación del peso E-z de estos prematuros.
Asunto(s)
Aumento de Peso , Recién Nacido , Lactante , Humanos , Edad Gestacional , Estudios Longitudinales , Estudios Retrospectivos , Peso al NacerRESUMEN
Introduction: Introduction: the follow-up of small for gestational age (SGA) preterm infants is critical due to their differentiated postnatal growth pattern. Objective: to investigate the weight z-score behavior in SGA preterm infants during a four-week stay in a Neonatal Intensive Care Unit. Methods: a retrospective longitudinal study with data from nutritional anamneses of 190 preterm infants admitted to a Neonatal Intensive Care Unit between January/2017 and December/2019, classified according to nutritional status at birth as either SGA or appropriate for gestational age (AGA). Linear regression was used to verify association between weight z-score with gestational age, birth weight, initiation of enteral nutrition and relative amount of energy and protein administered. Results: SGA preterm infants accounted for 23 % of the study participants. In SGA, the difference in weight score was observed at week 1 when compared to admission (p < 0.05), while in AGA there was a difference sustained during the whole period (p < 0.05). In SGA, the linear regression analysis showed that the change in z-score was explained by time to start of enteral nutrition (p = 0.033), gestational age (p = 0.003) and birth weight (p = 0.001). In AGA the change was explained by gestational age (p = 0.000) and birth weight (p = 0.000). Conclusion: the weight z-score behavior in preterm infants was downward compared to admission, stable at the end of 4 weeks, and different according to nutritional status at birth. In the AGA group the decline in nutritional status was not recovered throughout hospitalization and in the SGA group the unfavorable nutritional status was maintained.
Introducción: Introducción: el seguimiento de los prematuros pequeños para la edad gestacional (PEG) es crítico debido al patrón de crecimiento posnatal diferenciado. Objetivo: investigar el comportamiento de la puntuación z del peso en recién nacidos prematuros PEG durante cuatro semanas de estancia en una unidad de cuidados intensivos neonatales. Métodos: estudio longitudinal retrospectivo con datos de anamnesis nutricionales de 190 prematuros ingresados en una unidad de cuidados intensivos neonatales entre enero/2017 y diciembre/2019, clasificados según el estado nutricional al nacer como PEG o como adecuado para la edad gestacional (AEG). Se utilizó la regresión lineal para verificar la asociación entre la puntuación z del peso con la edad gestacional, el peso al nacer, el inicio de la nutrición enteral y la cantidad relativa de energía y proteínas administradas. Resultados: los bebés prematuros PEG representaron el 23 % de los participantes en el estudio. En el grupo PEG, la diferencia de la puntuación z del peso se observó en la semana 1 en comparación con el ingreso (p < 0,05), mientras que en el grupo AEG hubo diferencia durante todo el período evaluado (p < 0,05). En los PEG, el análisis de regresión lineal mostró que el cambio de la puntuación z se explicaba por el tiempo transcurrido hasta el inicio de la nutrición enteral (p = 0,033), la edad gestacional (p = 0,003) y el peso al nacer (p = 0,001). En el caso de la AEG, el cambio se explicaba por la edad gestacional (p = 0,000) y el peso al nacer (p = 0,000). Conclusión: el comportamiento de la puntuación z del peso en los prematuros fue descendente en comparación con la admisión, estable al final de 4 semanas y diferente según el estado nutricional al nacer. En el caso de los AEG, el estado nutricional no se recuperó a lo largo de la investigación y, en el caso de los PEG, el estado nutricional desfavorable se mantuvo.
Asunto(s)
Recien Nacido Prematuro , Recién Nacido Pequeño para la Edad Gestacional , Peso al Nacer , Femenino , Retardo del Crecimiento Fetal , Edad Gestacional , Humanos , Lactante , Recién Nacido , Estudios Longitudinales , Estudios RetrospectivosRESUMEN
Altered astrocytic function is a contributing factor to the development of neurological diseases and neurodegeneration. Berry fruits exert neuroprotective effects by modulating pathways involved in inflammation, neurotransmission, and oxidative stress. The aim of this study was to examine the effects of the lingonberry extract on cellular viability and oxidative stress in astrocytes exposed to lipopolysaccharide (LPS). In the reversal protocol, primary astrocytic cultures were first exposed to 1 µg/mL LPS for 3 h and subsequently treated with lingonberry extract (10, 30, 50, and 100 µg/mL) for 24 and 48 h. In the prevention protocol, exposure to the lingonberry extract was performed before treatment with LPS. In both reversal and prevention protocols, the lingonberry extracts, from 10 to 100 µg/mL, attenuated LPS-induced increase in reactive oxygen species (around 55 and 45%, respectively, P < 0.01), nitrite levels (around 50 and 45%, respectively, P < 0.05), and acetylcholinesterase activity (around 45 and 60%, respectively, P < 0.05) in astrocytic cultures at 24 and 48 h. Also, in both reversal and prevention protocols, the lingonberry extract also prevented and reversed the LPS-induced decreased cellular viability (around 45 and 90%, respectively, P < 0.05), thiol content (around 55 and 70%, respectively, P < 0.05), and superoxide dismutase activity (around 50 and 145%, respectively, P < 0.05), in astrocytes at both 24 and 48 h. Our findings suggested that the lingonberry extract exerted a glioprotective effect through an anti-oxidative mechanism against LPS-induced astrocytic damage.
Asunto(s)
Acetilcolinesterasa/metabolismo , Astrocitos/metabolismo , Lipopolisacáridos/farmacología , Neuroglía/metabolismo , Fármacos Neuroprotectores/farmacología , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/farmacología , Vaccinium vitis-Idaea/química , Animales , Animales Recién Nacidos , Antioxidantes/metabolismo , Astrocitos/efectos de los fármacos , Astrocitos/enzimología , Biomarcadores/metabolismo , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Neuroglía/efectos de los fármacos , Óxido Nítrico Sintasa de Tipo II/metabolismo , Ratas Wistar , Especies Reactivas de Oxígeno/metabolismo , Compuestos de Sulfhidrilo/metabolismoRESUMEN
Anthocyanins (ANT) are polyphenolic flavonoids with antioxidant and neuroprotective properties. This study evaluated the effect of ANT treatment on cognitive performance and neurochemical parameters in an experimental model of sporadic dementia of Alzheimer's type (SDAT). Adult male rats were divided into four groups: control (1 ml/kg saline, once daily, by gavage), ANT (200 mg/kg, once daily, by gavage), streptozotocin (STZ, 3 mg/kg) and STZ plus ANT. STZ was administered via bilateral intracerebroventricular (ICV) injection (5 µl). ANT were administered after ICV injection for 25 days. Cognitive deficits (short-term memory and spatial memory), oxidative stress parameters, and acetylcholinesterase (AChE) and Na+-K+-ATPase activity in the cerebral cortex and hippocampus were evaluated. ANT treatment protected against the worsening of memory in STZ-induced SDAT. STZ promoted an increase in AChE and Na+-K+-ATPase total and isoform activity in both structures; ANT restored this change. STZ administration induced an increase in lipid peroxidation and decrease in the level of antioxidant enzymes, such as superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx), in the cerebral cortex; ANT significantly attenuated these effects. In the hippocampus, an increase in reactive oxygen species (ROS), nitrite and lipid peroxidation levels, and SOD activity and a decrease in CAT and GPx activity were seen after STZ injection. ANT protected against the changes in ROS and antioxidant enzyme levels. In conclusion, the present study showed that treatment with ANT attenuated memory deficits, protected against oxidative damage in the brain, and restored AChE and ion pump activity in an STZ-induced SDAT in rats.